LGC acquires the Lipomed Reference Standards business, enhancing global portfolio of analytical reference materials

Today, LGC announced the acquisition of Lipomed AG’s reference materials business including standards with drugs of abuse and toxicology applications, and thus greatly complementing LGC’s reference standards offering.

Lipomed Reference Standards is a leading manufacturer and supplier of analytical reference standards with ISO/IEC 17025 accreditations for testing and ISO 17034 accreditation for production of reference materials. The business currently has manufacturing operations in Switzerland and a sales and distribution base in Cambridge, MA, USA, and this transaction will add a range of innovative products which are marketed and distributed in more than 50 countries around the world.

Ken Yoon, Executive Vice President & General Manager, LGC Standards, said, “We are really excited to be bringing Lipomed’s innovative reference standards team into LGC. Their drugs of abuse and toxicology portfolio will be a great fit with the LGC Standards business unit. We look forward to combining Lipomed’s and LGC’s expertise to deliver excellent solutions for our customers and to continue our mission of delivering Science for a Safer World.”